{"id":562913,"title":"Draft guidance on proposed new Clinical Trials Regulations (GUI-0100) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T10:17:08.093000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-modernizing-framework-clinical-trials/draft-guidance-proposed-new-regulations-gui-0100.html","snippet":"Draft guidance on proposed new Clinical Trials Regulations (GUI-0100) This draft guidance is for consultation only. For current guidance please see the existing guidance document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human…","rawSnapshotUrl":"/api/snapshots/raw/562913","browseUrl":"https://replay.healtharchive.ca/job-6/20260216101708/https://www.canada.ca/en/health-canada/programs/consultation-modernizing-framework-clinical-trials/draft-guidance-proposed-new-regulations-gui-0100.html#ha_snapshot=562913","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}